Brett L. Hurst
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research 12
- COVID-19 Clinical Research Studies 4
- Viral gastroenteritis research and epidemiology 4
- Computational Theory and Mathematics top 0.5%
- Immunology top 10%
- interferon and immune responses 4
- Epidemiology top 5%
- Respiratory viral infections research 17
- Influenza Virus Research Studies 16
- Virology top 10%
-
- Viral Infections and Immunology Research 7
-
- Virus-based gene therapy research 6
- Co-authors
- E. Bart TarbetDonald F. SmeeChunlong MaJun WangYanmei HuJulia A. TownsendYu ChenMichael T. Marty
- Journals
- Antiviral Research (8 papers)Antiviral chemistry & chemotherapy (6 papers)Vaccine (4 papers)
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Brett L. Hurst
52 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Infectious Diseases 1.1k
- Computational Theory and Mathematics 678
- Immunology 309
- Epidemiology 503
- Virology 49
Countries citing papers authored by Brett L. Hurst
This map shows the geographic impact of Brett L. Hurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett L. Hurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett L. Hurst more than expected).
Fields of papers citing papers by Brett L. Hurst
This network shows the impact of papers produced by Brett L. Hurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett L. Hurst. The network helps show where Brett L. Hurst may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brett L. Hurst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 8 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 52 | |
| 11 | Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main proteasebreakdown → | 2020 | 616 |
| 12 | 2019 | 13 | |
| 13 | 2018 | 26 | |
| 14 | 2018 | 34 | |
| 15 | 2017 | 96 | |
| 16 | 2017 | 49 | |
| 17 | 2014 | 15 | |
| 18 | 2013 | 27 | |
| 19 | 2013 | 6 | |
| 20 | 2009 | 81 |
About Brett L. Hurst
Brett L. Hurst is a scholar working on Infectious Diseases, Virology and Epidemiology, having authored 52 papers that have together received 2.1k indexed citations. Recurring topics across this work include Respiratory viral infections research (17 papers), Influenza Virus Research Studies (16 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Viral Infections and Immunology Research (7 papers), Virus-based gene therapy research (6 papers), interferon and immune responses (4 papers), COVID-19 Clinical Research Studies (4 papers) and Viral gastroenteritis research and epidemiology (4 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Computational Theory and Mathematics (678 citations) and Immunology (309 citations). Brett L. Hurst has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include E. Bart Tarbet, Donald F. Smee, Chunlong Ma, Jun Wang, Yanmei Hu, Julia A. Townsend, Yu Chen, Michael T. Marty, M. Sacco and Xiujun Zhang. Their work appears in journals such as Antiviral Research, Antiviral chemistry & chemotherapy, Vaccine, Viruses and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.